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Edited by D De BeerThe popular South African herbal tea, honeybush, is made from several Cyclopia species (family: Fabaceae),
amongst them Cyclopia genistoides. Phytoestrogenic potential of C. genistoides. has been recently reported,
however bioactivity-guided isolation of compounds with estrogenic activity has not yet been performed.
A transgenic plant system, Arabidopsis thaliana pER8:GUS, was used to assay the estrogen-like activity of
C. genistoides. The quantitative determination of the active compounds in the fermented and non-fermented
plant material was performed by HPLC. Subsequent bioactivity-guided fractionation led to the isolation of
genistein, naringenin, isoliquiritigenin, luteolin, helichrysin B and 5,7,3′,5′-tetrahydroxyﬂavanone, four of them
ﬁrst reported in the genus.
Helichrysin B, naringenin and 5,7,3′,5′-tetrahydroxyﬂavanone differed in quantity in the fermented and unfer-
mented herbs, the fermented plant material contained two compounds with substantial estrogenic-like activity
in higher concentration (naringenin and 5,7,3′,5′-tetrahydroxyﬂavanone), whereas the less active helichrysin B
was more abundant in the unfermented herb. The fractions as well as compounds inhibited the growth of
human cancer cell lines A2780 and T47D.
These results underline the phytoestrogenic activity of C. genistoides and support the rationale to the fermenta-
tion process.
© 2016 SAAB. Published by Elsevier B.V. All rights reserved.Keywords:
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Luteolin1. Introduction
Current hormone replacement therapy (HRT), using conjugated
equine estrogen alone (CEE) for women who had undergone hysterec-
tomy or in combinationwith progestin (CEE+P) forwomenwith intact
uterus, proved to lack overall beneﬁt in chronic disease prevention
(osteoporosis, heart disease) and menopausal symptom alleviation
(Anderson et al., 2004; Rossouw et al., 2002). Moreover, CEE+P in-
creases the risk of stroke, coronary heart disease, venous thromboem-
bolic disease and breast cancer, while CEE alone does not affect the
risk of heart disease, but increases the risk of stroke (Anderson et al.,
2004; Rossouw et al., 2002). Alternative solutions, such as selective
estrogen receptor modulators (SERMs) have been also questioned.EE, conjugated equine estrogen;
ith progestin; SERM, selective
ptors; E2, 17-β-estradiol; XVE,
curonidase; MAC, minimum ac-
. Csupor), kobus.eloff@up.ac.za
hts reserved.
activity guided isolation of ph
tany (2016), http://dx.doi.orgHowever, the well-known SERMs, raloxifene and tamoxifen, have
been reported to decrease the risk of breast cancer and increase bone
mineral density, but they have also been associatedwith the stimulation
of endometrial growth, the occurrence of hot ﬂashes and an increased
risk of venous thromboembolism (Barrett-Connor et al., 2006; Cranney
and Adachi, 2005; Delmas et al., 1997; MacGregor and Jordan, 1998;
Vosse et al., 2002; Zidan et al., 2004).
Phytoestrogens might serve as a viable alternative for HRT, given
their differentiated effect on α and β estrogen receptors (ERs). They
may be able to bind to both ER subtypes, acting as either agonist or
antagonist, but unlike 17-β-estradiol (E2) they generally bind to the
ER with a much lower afﬁnity, yet have a higher afﬁnity for ER-β than
for ER-α, which is believed to protect against excessive cell proliferation
mediated by ER-α (Lindberg et al., 2003; Morito et al., 2001).
Most of the studies concerning phytoestrogens have focused on
soybean and one of its isoﬂavones, genistein, due to epidemiological
evidence suggesting that Asian diet rich in soy is protective against
hormone-induced cancers such as breast and prostate cancer (Morton
et al., 2002). Furthermore, phytoestrogensmay be beneﬁcial to alleviate
menopausal symptoms and to protect postmenopausal women against
cardiovascular disease and osteoporosis, without the risks associatedytoestrogenic compounds from Cyclopia genistoides by the pER8:GUS
/10.1016/j.sajb.2016.06.001
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ing studies, their effect onmenopausal symptoms, such as hot ﬂushes, is
inconclusive, and the phytoestrogen treatment seems to be less effec-
tive than traditional HRT (Glazier, 2001; Lethaby et al., 2013). Yet, the
risks of HRT and the increasing popularity of natural products provide
a rationale to search for phytoestrogens with selective afﬁnity for ERs.
One of the potential sources of phytoestrogens is the Cyclopia genus.
The popular caffeine free herbal tea, honeybush, comprises Cyclopia
species (family: Fabaceae), amongst them Cyclopia genistoides (L.)
Vent., which is native to the western cape province of South Africa.
Honeybush is traditionally used as a restorative or expectorant, but an-
ecdotal evidence also exists about its consumption in order to stimulate
milk production in breast-feeding women and to alleviate menopausal
symptoms (Joubert et al., 2008; Verhoog et al., 2007b). Methanol
extracts from C. genistoides was also reported to consistently have the
highest binding afﬁnity for both ER subtypes in whole-cell competitive
receptor binding assays, when comparing four Cyclopia species
(Verhoog et al., 2007b). Recently, the phytoestrogenic potential of ex-
tracts from different Cyclopia species was reported, as well as some com-
pounds, present in Cyclopiawere also tested (Louw et al., 2013; Verhoog
et al., 2007a, 2007b; Visser et al., 2013). However bioactivity-guided iso-
lation was reported from Cyclopia subternata, but not from C. genistoides,
which species also displayed signiﬁcant phyto-estrogenic activity
(Mortimer et al., 2015; Verhoog et al., 2007b).
Comprehensive phytochemical investigations of Cyclopia species
have focused on the polyphenolic composition of three out of the
six commercially important species, Cyclopia intermedia, C. subternata
and C. genistoides. The aerial parts of Cyclopia contain mainly ﬂavones
(luteolin, scolymoside, diosmetin), ﬂavanones (naringenin,
eriodictyol, hesperitin, narirutin), isoﬂavones (formononetin, wistin,
calycosin, orobol, afrormosin, fujikinetin, pseudobaptigen), xanthones
(mangiferin, isomangiferin), coumestans (medicagol,ﬂemmichapparin,
sophoracoumestan), catechins (epigallocatechin-3-O-gallate), benzal-
dehyde derivates and phenylethanolderivates (Ferreira et al., 1998;
Joubert et al., 2008; Joubert et al., 2011; Kamara et al., 2004; Sprent
et al., 2010).
A comprehensive phenolic proﬁling of C. genistoides by the means
of LC-DAD–MS and –MS/MS has been recently performed. Ten
compounds were identiﬁed based on comparison with reference
standards (iriﬂophenone-3-C-glucoside, eriocitrin, narirutin,
vicenin-2, diosmin, etc), thirty constituents were tentatively identi-
ﬁed (e.g. tetrahydroxyxanthone-C-hexoside dimers, naringenin
derivates, eriodyctiol glycosides, phloretin-3′,5′-di-C-glucoside,
glycosidated phenolic acids) (Beelders et al., 2014).
Also recently, a fast and efﬁcient method for the isolation of
the C-glucosidated xanthones mangiferin and isomangiferin from
C. genistoides was developed and additionally, two benzophenone de-
rivatives: 3-C-β-glucosides of maclurin and iriﬂophenonewere isolated
together with hesperidin and luteolin (Kokotkiewicz et al., 2013).
In the present study, the methanol extracts from fermented and un-
fermented C. genistoideswere assayedwith a highly efﬁcient and conve-
nient transgenic plant system, Arabidopsis thaliana pER8:GUS line, in
order to detect estrogenic/antiestrogenic activity. The transgenic plant
pER8:GUS, with the GUS gene as a gene fusion marker for the analysis
of gene expression, expresses high estrogenic sensitivity and can be
used to quantify the bioactivity of phytoestrogens (Lai et al., 2011).
Moreover, it is a visible system, and primary results can be readily ob-
served visually, without the need of special instrumentation. The sys-
tem contains an estrogen receptor-based transactivator vector (XVE)
as an activator unit and the GUS (β-glucuronidase) gene as a reporter
(Brand et al., 2006). The XVE system is an estrogen receptor-based
chemical-inducible system, which was developed by Zuo et al. in
2000. It comprises a DNA binding domain of the bacterial repressor
LexA (X), an acidic transactivating domain of VP16, and the regulation
region of the ER-α. The XVE activator is strictly regulated by estradiol;
in the case of the presence of estrogen active compounds the activatorPlease cite this article as: Roza, O., et al., Bioactivity guided isolation of ph
reporter system, South African Journal of Botany (2016), http://dx.doi.orgstimulates expression of GUS transcription (Brand et al., 2006). GUS
protein containing transgenic plants gives blue color, after adding a
glucopyranosiduronic acid containing dye.
The cost-effectiveness, tolerance toward higher doses of cytotoxic
compounds, the ability to detect both ER agonists and antagonists and
high efﬁciency and versatility made pER8:GUS a convenient screening
system for testing estrogen-like effects. However, the pER8:GUS system
as used in the current study only screened for ERα agonists not antago-
nists, despite the fact that theoretically the systemmay be used to inves-
tigate antagonism if the test compounds are administered togetherwith
E2. Limitations of this transgenic plant assay may be its relative lower
sensitivity and that it only determines ER-α interactions. However,
phytoestrogens usually bind both ER-α and ER-β (with higher afﬁnity
toward ER-β), hence thismodel is suitable for natural product screening
(Brahmachari, 2015; Brand et al., 2006; Lai et al., 2013; Lai et al., 2011).
Bioactivity-guided fractionation led to the isolation of six com-
pounds, which were quantiﬁed by the means of HPLC.
With regard to the reported antiestrogenic and estrogenic activity of
Cyclopia extracts, fractions and compounds, they can induce and/or
inhibit cell-proliferation, depending on their amount, structure, the
ERα/β ratio of the cells, the presence of E2, ERα/β antagonism/
antagonism or ER-independent antiproliferative effect of the com-
pounds and their ratio in an extract (Pons et al., 2014; Verhoog et al.,
2007a; Visser et al., 2013). In order to measure the antiproliferative ef-
fect of the isolated compounds, antiproliferative testing was conducted
on T47D and A2780 cells.
2. Materials and methods
2.1. General
Vacuum liquid chromatography (VLC) was carried out on silica gel G
(15 μm,Merck); column chromatography (CC) on polyamide (ICN), sil-
ica gel (160–200 mesh, Qingdao Marine Chemical Co., Qingdao, China)
and Sephadex LH-20 (Sigma); preparative thin-layer chromatography
(preparative TLC) on silica gel 60 F254 and 60 RP-18 F254 plates
(Merck); and rotation planar chromatography (RPC) on silica gel 60
F254 (Merck) using a Chromatotron instrument (Model 8924, Harrison
Research). Medium pressure liquid chromatography (MPLC) was per-
formed by a Büchi apparatus (Büchi Labortechnik AG, Flawil) using a
40 × 150 mm RP18ec column (40–63 μm, Büchi).
The instrumentation for normal-phase HPLC (NP-HPLC) consisted of
aWaters Alliance 2695 separationsmodule connected to aWaters 2998
photodiode array (PDA) detector (190–800 nm), (Waters Associates,
Milford, MA, USA). The separation was carried out on a Kinetex C18
(5 μm, 100 Å, 150 × 4.6 mm) column (Phenomenex, Torrance, USA).
For the preparative reversed-phase HPLC, a Merck Hibar Purospher
STAR C18 (5 μm, 250 × 10.0 mm) semipreparative column (Merck
KGaA, Darmstadt, Germany) was used, and HPLC equipment consisted
of two JASCO PU-2080 HPLC pumps connected to a JASCO MD-2010
Plus multi-wavelength detector (JASCO Inc., Tokyo, Japan).
1H NMR (500MHz), 13C NMR (125MHz) and 2D NMRwere record-
ed in CD3OD or CDCl3 or DMSO using a Bruker Avance DRX 500 spec-
trometer or a JEOL ECS 400 MHz FT-NMR spectrometer. The signals of
the deuterated solvents were taken as reference. Two-dimensional
(2D) experiments were performed with standard Bruker software. MS
spectra were recorded on a API 2000 Triple Quad mass spectrometer
with APCI ion source using positive polarity.
2.2. Plant material
Fermented and non-fermented C. genistoides (L.) Vent. were a gift
from Van Zyl and Mona Joubert owners of Agulhas Honeybush Tea, on
their farm near Bredasdorp in South Africa. Botanical identiﬁcations
were performed by Dr. Hannes de Lange. Fermentation was carried
out according to the traditional method for this material [http://www.ytoestrogenic compounds from Cyclopia genistoides by the pER8:GUS
/10.1016/j.sajb.2016.06.001
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and 826-nF) for both the fermented and the unfermented plants have
been deposited at the herbarium of the Department of Pharmacognosy,
University of Szeged, Szeged, Hungary.2.3. Extraction and isolation
The dried fermented and unfermented plant materials (1.7 and
1.3 kg, respectively) were extracted by ultrasonication with methanol
(12 L and 10 L) at room temperature for 30 min. The solvent was
evaporated under reduced pressure to yield 228.2 g and 237.6 g of
crudeMeOHextracts, respectively. These extractswere subjected to sol-
vent–solvent partition, affording n-hexane (fermented: 15.7 g, unfer-
mented: 13.2 g), dichloromethane (14.8 g and 6.4 g), ethyl-acetate
fractions (29.7 g and 23.35 g), the remnant aqueous layers (128.7 g
and 121.4 g) and insoluble part. The layers were assayed for estrogen-
like activity using the transgenic plant pER8:GUS reporter system at
100 and 200 μg/mL. Estrogenic activity of the extracts was detected
via a histochemical assay for GUS activity. The EtOAc and CH2Cl2 layers
from both the fermented and unfermented plant materials had
estrogen-like activities and thus were subjected to further chromatog-
raphy. For the schematic detailing of the fractionation process see Fig. 1.
The 1H proton spectra of the CH2Cl2 layers from the unfermented
and fermented C. genistoides were similar, thus only the CH2Cl2 layer
from the fermented plant material was further examined. It was
separated into fourteen fractions by polyamide CC eluting with
MeOH–H2O (2:3 to 1:0). Fractions P8–P11 had signiﬁcant estrogenic
activity (minimum active concentration (MAC) ≤200 μg/mL).Fig. 1. Bioactivity guided fractionation of the methanolic extracts of fermented and unferment
tetrahydroxyﬂavanone. Comp 3: compound 3, genistein. Comp 4: compound 4, isoliquiritigenin
chromatography— polyamide. OCC-NP: open column chromatography— normal phase silica ge
layer chromatography. OCC-Sph: open column chromatography— Sephadex LH-20. VLC-NP: v
Please cite this article as: Roza, O., et al., Bioactivity guided isolation of ph
reporter system, South African Journal of Botany (2016), http://dx.doi.orgFraction P9 (1.68 g) was chromatographed by RPC on silica gel and
elutedwith cyclohexane–acetone (1:0 to 0:1) to give seven subfractions.
Subfractions T4 and T5 (410mg, 250mg, respectively)were subjected to
silica gel CC, elutedwith n-hexane–acetone (2:1 to 0:1 and 5:1 to 0:1, re-
spectively) to yield eleven (C1–C11) and eight (CD1–CD8) subfractions,
respectively. C3 and CD5 were puriﬁed by preparative TLC to provide
compounds 1 (16.8 mg) and 2 (7.4 mg), respectively.
Fraction P10 (475.5mg)was subjected to silica gel CC, elutedwith n-
hexane–acetone (3:1 to 0:1) to yield thirteen (CE1–CE13) subfractions.
CE8 was puriﬁed by RP-HPLC (Hibar, Rp-18e, 5 μm, MeOH–H2O, 3:2,
ﬂow rate 2 mL/min) and also by preparative TLC (CH2Cl2–MeOH
10:0.15) to yield compound 4 (1.65 mg) and compound 3 (1.4 mg)
respectively.
Fraction P11 (245 mg) was chromatographed by RPC on silica gel
and eluted with cyclohexane–acetone (1:0 to 0:1) to give ﬁfteen
subfractions. Subfraction S11 was further puriﬁed by Sephadex LH-20
to provide compound 5 (5.6 mg).
The 1H NMR spectra of the EtOAc layers from the unfermented and
fermented C. genistoides were similar, thus only the EtOAc layer from
the unfermented plant material was further examined. It was separated
into twelve fractions by VLC eluting with EtOAc–MeOH (1:0 to 0:1).
Fractions V2, V3, V6 and V7 had signiﬁcant estrogenic activity
(MAC ≤ 200 μg/mL). Fraction V7 was separated by MPLC with EtOAc–
MeOH–H2O (20:1:1 to 0:1:0) to yield 21 subfractions, M1 to M21.
Fraction M6 (777.5 mg) was separated into 12 subfractions by silica
gel MPLC eluting with MeOH–H2O (2:8 to 1:0). Subfraction M6/4
(55.3mg)was further puriﬁed by normal-phase preparative TLC eluting
with EtOAc–MeOH–H2O (100:16:14) and ﬁnally by gel ﬁltration chro-
matography to provide compound 6 (3.3 mg).ed Cyclopia genistoides. Comp 1: compound 1, naringenin. Comp 2: compound 2, 5,7,3′,5′-
. Comp 5: compound 5, luteolin. Comp 6: compound 6, helichrysin B. OCC-P: Open column
l. RPC-NP: rotation planar chromatography—normal phase silica gel. PLC: preparative thin
acuum liquid chromatography — normal phase silica gel.
ytoestrogenic compounds from Cyclopia genistoides by the pER8:GUS
/10.1016/j.sajb.2016.06.001
4 O. Roza et al. / South African Journal of Botany xxx (2016) xxx–xxx2.4. Transgenic plant material and estrogen-like reporter assay
pER8:GUS seeds were grown in the dark for 24–36 h at 4 °C on
medium (1/2 MS, 1% sucrose, 0.8% phytoagar) for vernalization and
then germinated under white light for 72 h at 24 °C. The plants were
transferred to a 24-well microtiter plate in the presence or absence of
test samples and incubated at 24 °C for 48 h. 3–5 transgenic plants
were added to each well, in order to evaluate estrogenic activity. Plants
cultured with 0.31–10 nM 17β-estradiol were taken as a positive
control.
2.5. Histochemical assay
After incubation in the presence or absence of test samples, trans-
genic plants were soaked in 0.2 mL per well of the GUS assay solution
[50 mM Na3PO4 buffer (pH 7.0), 10 mM EDTA (pH 8.0), 2 mM X-Gluc,
0.5 mM K3Fe(CN)6, 0.5 mM K4Fe(CN)6, and 0.1% Triton X-100] in a 24-
well plate and incubated for 3 h or overnight at 37 °C. Then afterFig. 2. Estrogenic MAC of the isolated active compounds in the histochemical assay. The concent
with red boxes. The last/only concentration where the blue color was still detectable was consi
this ﬁgure legend, the reader is referred to the web version of this article.)
Please cite this article as: Roza, O., et al., Bioactivity guided isolation of ph
reporter system, South African Journal of Botany (2016), http://dx.doi.orgwashing, 70% aqueous EtOH was used to remove chlorophyll. Using a
ZEISS Axiovert 200 inverse microscope, samples were examined for
GUS staining and photographed with a digital camera. The minimum
active concentration (MAC) of each sample was recorded upon the dis-
appearance of the insoluble blue dye (5,5′-dibromo-4,4′-dichloro-
indigo). The last concentration in the series, where the blue color was
still detectable was considered the minimum active concentration. The
parallel experiments were in accordance, hence no SEM/SD were
calculated.
2.6. HPLC quantitative determination
Chromatographic analyses of the aqueous “cup of tea” (100mL boil-
ing tap water + 4 g plant material, 10 min) and methanolic (10 mL
MeOH + 1 g plant material, 10 min, ultrasonication) extracts were
performed on the Waters HPLC module. The separation was carried
out on a Kinetex C18 column (5 μm, 100 Å, 150 × 4.6mm, Phenomenex,
Torrance, USA), operated at 20 °C. Chromatographic elution wasrationswhere the blue color was detectable, indicating estrogenic activity, are surrounded
dered the minimum active concentration. (For interpretation of the references to colors in
ytoestrogenic compounds from Cyclopia genistoides by the pER8:GUS
/10.1016/j.sajb.2016.06.001
Table 1
Fractions and compounds exhibiting substantial (above 30) antiproliferative activity
against either A2780 or T47D cells.
Growth inhibition (%) ± SEM
Substance Concentration (μg/mL) A2780 T47D
V3 10 83.83 ± 0.78 50.90 ± 0.98
30 88.35 ± 0.28 69.95 ± 0.57
V4 10 –a 11.06 ± 1.20
30 16.16 ± 2.96 33.76 ± 1.57
P7 10 – 12.54 ± 2.90
30 42.83 ± 1.27 40.07 + 1.59
P8 10 22.27 ± 2.34 40.81 ± 2.38
30 43.44 ± 1.02 48.73 ± 0.97
P10 10 26.42 ± 1.97 44.97 ± 2.67
30 39.90 ± 0.90 50.16 ± 2.29
P11 10 22.06 ± 2.58 32.90 ± 2.67
30 51.97 ± 1.01 44.42 ± 1.76
Luteolin 10 53.43 ± 0.82 37.43 ± 2.35
30 91.60 ± 0.61 65.10 ± 1.17
Genistein 10 39.40 ± 1.33 14.98 ± 1.50
30 84.79 ± 0.59 39.02 ± 1.30
Naringenin 10 15.95 ± 0.97 –
30 41.42 ± 2.19 22.64 ± 1.30
Isoliquiritigenin 10 19.53 ± 1.86 –
30 71.13 ± 0.64 36.50 ± 2.11
a Conditions exerting inhibition less than 10% are considered ineffective and the exact
values are not presented for clarity. All the presented results are statistically different (p b
0.05) from the untreated control cells.
5O. Roza et al. / South African Journal of Botany xxx (2016) xxx–xxxaccomplished by gradient solvent system consisting of MeOH and acid-
iﬁed H2O (0.1% H3PO4); injection volume was 20 μl The gradient
consisted three steps, for 21 min the % of the acidiﬁed water decreased
from 80% to 24% then in 1 min it reached 80% again, then for 6 min this
ratio wasmaintained. Peaks were identiﬁed by comparison of retention
times and UV–vis spectra (PDA detector) with those of the isolated
compounds.
2.7. Antiproliferative assay
The antiproliferative properties of the prepared extracts and natural
products were determined on two human cancerous cell lines (pur-
chased from ECACC, Salisbury, UK) by using the MTT assay. A2780 and
T47D cells (isolated from ovarian and breast carcinoma, respectively),
were cultivated in minimal essential medium supplemented with 10%
fetal bovine serum, 1% non-essential amino acids and an antibiotic–
antimycotic mixture. All media and supplements were obtained from
PAA Laboratories GmbH, Pasching, Austria. Near-conﬂuent cancer cells
were seeded onto a 96-well microplate (5000/well) and attached to
the bottom of the well overnight. On the second day, 200 μL of newme-
dium containing the tested substances (at 10 or 30 μg/mL) was added.
After incubation for 72 h at 37 °C in humidiﬁed air with 5% CO2, the liv-
ing cells were assayed by the addition of 20 μL of 5 mg/mLMTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] solution. MTT
was converted by intact mitochondrial reductase and precipitated as
blue crystals during a 4 h contact period. The medium was then re-
moved and the precipitated crystals were dissolved in 100 μL of DMSO
during a 60 min period of shaking at 25 °C. Finally, the reduced MTT
was assayed at 545 nm, using amicroplate reader; wells with untreated
cells were used as controls (Mosmann, 1983). All experimentswere car-
ried out on two microplates with at least ﬁve parallel wells. Stock solu-
tions of the tested substances (10 mg/mL) were prepared with DMSO.
The highest DMSO content of the medium (0.3%) did not have any sub-
stantial effect on the cell proliferation. Cisplatin was used as reference
agent which inhibited the proliferation of A2780 and T47D cells with
IC50 values of 1.30 and 9.78 μM, respectively. Statistical evaluation of
the results was performed by one-way analysis of variance followed
by the Dunnett posttest, using GraphPad Prism 4 (GraphPad Software,
San Diego, CA, USA).
3. Results and discussion
3.1. Histochemical assay
The CH2Cl2 and EtOAc extracts of the fermented and unfermented
C. genistoides were active (MAC 200 μg/mL) and were selected for
bioactivity-guided fractionation, by using HPLC, MPLC, RPC, CC and pre-
parative TLC. From the CH2Cl2 fraction of the fermented plant material
four out of fourteen subfractions, yielded via polyamide column chro-
matography, had estrogenic like effects (P8–P11, MAC 200 μg/mL). P8
and P11 contained one, P9 two and P10 three of the isolated active
compounds. From the EtOAc fraction of the unfermented C. genistoides
four out of twelve VLC subfractions were active (200 μg/mL) in the
estrogen-like reporter assay (V2, V3, V6, V7). One, two and two active
constituents were found in V7, V2 and V3 subfractions, respectively.
Bioassay-directed chromatographic fractionation led to sixﬂavonoids
with estrogenic activity. Compounds 1, 2, 3, 4, 5 and 6 proved to be
naringenin, 5,7,3′,5′-tetrahydroxyﬂavanone, genistein, isoliquiritigenin,
luteolin and helichrysin B (naringenin-5-O-glucoside), respectively. The
compounds were identiﬁed by comparing their physical and spectro-
scopic data with reported data and by APCIMS/MS (Andrade et al.,
2010; Nessa et al., 2004; Patora and Klimek, 2002; Zhao et al., 2011).
Fractions P8 and P10 were analyzed by HPLC, compounds 1 and 2were
detected from these fractions as well, respectively. In fractions V2 com-
pounds 1 and 2 and in fraction V2 compound 2was also detected.Please cite this article as: Roza, O., et al., Bioactivity guided isolation of ph
reporter system, South African Journal of Botany (2016), http://dx.doi.orgThe least potent compound was the helichrysin B with a MAC of
115 μM (Fig. 2). Two compounds, which have not yet been isolated
from C. genistoides, genistein and isoliquiritigenin had substantial activ-
ity with a MAC of b11.56 and 12.19 μM. Luteolin, naringenin and
5,7,3′,5′-tetrahydroxyﬂavanone also had estrogen-like activity with
MACs of 87.5, 23 and 86.5 μM. The minimum active concentration of
the control, 17-β-estradiol (E2) was 2.5 nM. In a previous study, using
the same transgenic plant system pER8:GUS, the minimum active con-
centration of E2 was found to be lower, 0.62–1.25 nM (Lai et al., 2011).
The constituents luteolin, genistein, isoliquiritigenin and naringenin
are well-known phytoestrogens. Naringenin, luteolin and genistein
were able to displace 70%, 92% and 95% of the 3H-E2 from hERβ, exerting
the highest displacements when 10 phytoestrogens were compared
(Verhoog et al., 2007b). Phytoestrogens have the potential to maintain
bone health and delay or prevent osteoporosis, one of the postmeno-
pausal symptoms. Genistein was found to have positive effects on
bone mineral density on osteopenic postmenopausal women (Marini
et al., 2007). Isoliquiritigenin is also a promising agent for bone destruc-
tive diseases (Liu et al., 2016). Next to their effect on the bone they also
possess other activities, potentially important in the treatment of
postmenopausal symptoms. Genistein and luteolin suppressed the in-
duction of the proliferation-stimulating activity of environmental estro-
gens, suggesting anti-estrogenic and anti-cancer effect (Han et al.,
2002); and naringenin attenuated many of the metabolic disturbances
associated with ovariectomy in female mice (Ke et al., 2015). Genistein
was also associated with favorable effects on both glycemic control and
some cardiovascular risk markers (Atteritano et al., 2007). Regular
grapefruit juice (contains high amounts of naringenin) consumption
by middle-aged, healthy postmenopausal womenwas found to be ben-
eﬁcial for arterial stiffness.
Their presence gives a rationale to the traditional use of honeybush
tea. Although, in the literature different extracts from different Cyclopia
species exerted varying phytoestrogenic activity, even between
harvestings, questioning the real potential of the infusion in medicinal
use.
3.2. Antiproliferative assays
In Table 1, fractions and compounds with inhibition values above
30% either in A2780 or T47D cells are displayed. While in the pER8:GUSytoestrogenic compounds from Cyclopia genistoides by the pER8:GUS
/10.1016/j.sajb.2016.06.001
Table 2
The quantitative determination of the active compounds.
Compound
MeOH extract Aqueous extract
LOD
(μg)
LOQ
(μg)
Fermented
(mg/g dried plant material)
Unfermented
(mg/g dried plant material)
Fermented
(mg/g dried plant material)
Unfermented
(mg/g dried plant material)
Luteolin 0.0439 ± 0.00622 0.0511 ± 0.01439 0.0152 ± 0.00123 0.0174 ± 0.00622 0.2260 0.7533
Naringenin 0.1334 ± 0.01224 0.0037 ± 0.00047 0.0391 ± 0.00160 0.0027 ± 0.00003 0.1880 0.6268
Genistein n.d. n.d. n.d. n.d. 0.2578 0.8594
Isoliquiritigenin 0.0038 ± 0.00061 0.0026 ± 0.00007 n.d. n.d. 0.3125 1.0416
5,7,3′,5′-Tetrahydroxy-ﬂavanone 0.0842 ± 0.03007 0.0079 ± 0.00235 0.0489 ± 0.00762 n.d. 0.2750 0.9167
Helichrysin B 0.1623 ± 0.04625 0.2375 ± 0.09298 0.3279 ± 0.02610 0.3376 ± 0.05396 0.3290 1.0967
n.d. (not detected), LOD limit of detection, and LOQ limit of quantiﬁcation. Values are given in ±SD.
6 O. Roza et al. / South African Journal of Botany xxx (2016) xxx–xxxassay P8–11, V2, 3, 6, and 7 showed estrogenic activity; in the antipro-
liferative tests, P8, 10, 11 and V3 demonstrated inhibition greater than
30% in either cell-lines. Taking into consideration, that these fractions
are complex mixtures, other compounds than the active constituents
may have exerted antiproliferative activity.
Except for helichrysin B and 5,7.3′,5′-tetrahydroxyﬂavanone, all
active compounds (naringenin, luteolin, isoliquiritigenin, genistein) ex-
hibited substantial antiproliferative activity against the tested cell lines.
All four of them had a greater inhibition toward the ER negative A2780,
whichmay suggest an ER independent inhibition of cell-proliferation, or
possibly the induction of cell proliferation in the ER positive T47D cell-
line; underlining their estrogenic potential. The well-documented
ER-mediated actions of these ﬂavonoids cannot be excluded as a
component of their antiproliferative properties, however, in our current
experimental conditions the cell culture medium contained a substan-
tial amount of natural estrogens, as components of fetal bovine serum,
and therefore the obtained results do not support a direct relationship
between the two determined activities.3.3. HPLC quantiﬁcation
The quantitative comparison of the six active compounds between
the fermented and unfermented C. genistoides was performed by
RP-HPLC. While both the processed and unprocessed plants contained
similar amounts of luteolin and isoliquiritigenin, the naringenin and
5,7,3′,5′-tetrahydroxyﬂavanone content in the fermented honeybush
was more than 30 and 10 folds, respectively (Table 2). On the other
hand, the unfermented Cyclopia had higher quantities of the least effec-
tive naringenin-glycoside. Considering, that ﬂavonoid-glycosides may
degrade during the fermentation process, this might explain the differ-
ence in the amounts. 5,7,3′,5′-Tetrahydroxyﬂavanone and naringenin –
compoundsmore abundant in the fermented plantmaterial – displayed
stronger estrogen-like activity than helichrysin B, providing a rationale
to the fermentation process. The quantitative comparison of the extract
used for the bioactivity guided isolation (methanolic extract) and the
traditionally used aqueous extract (“cup of tea extract”) was also
performed. The “cup of tea” extracts, prepared with boiling tap water,
hadmuch lower concentrations of the active compounds. Isoliquiritigenin
was below the detection limit in aqueous extracts whereas 5,7,3′,5′-
tetrahydroxyﬂavanone was undetectable in the water extract of the
unfermented sample. Genistein was not detected in any of the extracts.
On one hand, although our experiments reported potent and well-
known phytoestrogens to be comprised by C. genistoides and the HPLC
quantiﬁcation underpinned the possible importance of fermentation pro-
cess, the low concentrations of the tested compounds are questioning the
potential phytoestrogenic activity of the traditionally usedhoneybush tea.
Estrogenic isoﬂavones, such as formononetin and calycosin shown to be
present in another Cyclopia species, C. subternata, but they were also not
observed in quantiﬁable amounts (Louw et al., 2013). Furthermore, in
the literature different extracts from different Cyclopia species exerted
varying phytoestrogenic activity, even between harvestings, adding to
the debate of the real potential of the infusion in medicinal use.Please cite this article as: Roza, O., et al., Bioactivity guided isolation of ph
reporter system, South African Journal of Botany (2016), http://dx.doi.orgOn the other hand, according to Verhoog et al. the aqueous extracts
of unfermented or fermented C. genistoides and C. subternatawere able
to signiﬁcantly to displace 1 nM 3H-E2 from hERβ. Although, this effect
was not observed in all tested harvestings, it did shown the possibility of
an aqueous extract to be estrogenic. It also has to be taken into account,
although that the isolated ﬂavonoids are present in small quantity, the
estrogenic activity of Cyclopia extracts is the result of a ﬁne balance
between different polyphenols present in varying amounts with
varying phytoestrogenic potential.
4. Conclusion
This is the ﬁrst bioactivity guided isolation of compounds with
estrogenic activity from fermented and unfermented C. genistoides sam-
ples, which provided six compounds, amongst them genistein, 5,7,3′,5′-
tetrahydroxyﬂavanone, helichrysin B and isoliquiritigenin, which have
not yet been reported from Cyclopia species. Antiproliferative MTT
assays were also performed, on A2780 and T47D cell-lines. The results
suggested that estrogen induced cell-proliferation or estrogen indepen-
dent antiproliferative effect might have played a role. The quantitative
determination of these compounds showed that two out of the ﬁve
active ﬂavonoid aglycons aremore abundant in the fermented plantma-
terial, another two are presented in similar amounts in the two kinds of
honeybush and one could not be detected with our method. The least
active ﬂavonoid-glycoside helichrysin B was more concentrated in the
unfermented C. genistoides.
Although, the quantitative comparison of fermented andunferment-
ed honeybush implies, that the fermented tea has a higher amount of
these phytoestrogens except the least active compound, the measured
low amounts question the biological activity of the traditionally used in-
fusion. However, it does not exclude the possibility that synergism or
antagonism of multiple polyphenols targeting multiple ER isoforms,
can result in the phytoestrogenic effect of different extracts, even if
the individual compounds are small in quantity.
There are plenty methods available for the evaluation of estrogenic
potential, yet the complexity of the mechanisms of action of
phytoestrogens andphytoestrogen containing herbal preparations trigger
divergent outcomes, depending on the method used, for example in the
case of transactivation, Cyclopia extracts displayed ERα antagonism and
ERβ agonism when ER subtypes were expressed separately, however,
when co-expressed only agonism was observed (Louw et al., 2013;
Visser et al., 2013). Considering that the pER8:GUS assay can identify all
compounds which are able to bind to ER-α (regardless of agonism or an-
tagonism), it is an ideal model for the preliminary investigation of plants
with proposed estrogen-like activities. Furthermore, while cytotoxicity is
a limiting factor of in vitro mammalian cell-based models, the transgenic
plant system expressed tolerance toward higher doses of cytotoxic
compounds (Lai et al., 2011).
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